--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Equate Heart Chart" developer_entity: "A&D Company, Limited" bundle_id: "jp.co.aandd.heartchart2" app_store_id: "1585198646" category: "Medical" primary_platform: "ios" primary_monetization: "Free" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2026-07-22" report_date: "2026-08-11" last_verified: "2026-08-11T00:00:00.000Z" report_version: "3.0.5" total_reviews: 13659 overall_rating: 4.6 sentiment: "Frustrated" sentiment_score: 25 confidence: "medium" confidence_score: 0.5 top_praise_theme: "Wireless blood pressure monitoring provides a convenient way to track heart health metrics over time" top_complaint_theme: "Bluetooth connectivity failures prevent the app from syncing readings from the monitor to the phone" review_sample_size: 99 total_review_count: 99 analyzed_review_count: 63 data_age_days: 12 momentum_velocity: "maintenance" intelligence_version: 3 tags: ["medical", "free", "frustrated sentiment", "mobile app", "app review", "app analysis", "individuals", "managing", "hypertension"] canonical_url: "https://marlvel.ai/apps/equate-heart-chart" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # Equate Heart Chart Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Free - **Signal**: Rating 4.62 · Sentiment Frustrated - **Recent focus**: Bluetooth connectivity failures prevent the app from syncing readings from the monitor to the phone (top complaint) · Wireless blood pressure monitoring provides a convenient way to track heart health metrics over time (top praise) > **TL;DR:** Equate Heart Chart is a medical app by A&D Company, Limited, rated 4.62/5 by 13.7K users, with Frustrated user sentiment (25/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** Equate Heart Chart faces Frustrated user sentiment (4.62/5 from 13.7K reviews), with users reporting bluetooth connectivity failures prevent the app from syncing readings from the monitor to the phone as the primary concern. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.62/5 (13.7K reviews) | | **User Mood** | Frustrated | | **Category** | Medical | | **Developer** | A&D Company, Limited | | **Pricing** | Free | | **Platforms** | iOS & Android | | **Confidence** | Medium (0.5/1.0) | | **Data Age** | 12d | ## Metadata & Market Performance - **Publisher:** A&D Company, Limited - **Category:** Medical - **Target Audience:** Individuals managing hypertension or cardiovascular health who own or intend to purchase Equate-branded Bluetooth blood pressure monitors. - **Platforms:** iOS & Android - **Version Reviewed:** 3.0.5 - **Report Date:** 2026-08-11 - **Signal Count:** 99 reviews analyzed - **Confidence:** Medium (0.5/1.0) - **App Store ID (iOS):** 1585198646 - **Bundle ID:** jp.co.aandd.heartchart2 - **Google Play ID:** jp.co.aandd.heartchart2 - **Performance Trend:** Mixed - **Data Window:** Analysis based on signals collected up to 2026-08-11 ## Executive Snapshot **What it is:** Equate Heart Chart is a health-tracking app for iOS and Android that syncs blood pressure data from specific Equate-branded Bluetooth monitors. **Why users hire it:** Users hire this app to automate the collection of blood pressure readings for physician review, reducing the manual effort of logging health history. ## App DNA (Features & Intent) - **[Differentiator] Swipe Averaging:** Calculates blood pressure averages for physician review via a gesture-based interface. - **[Differentiator] Bluetooth Device Sync:** Automated data ingestion from specific Equate-branded upper arm and wrist monitors. * *User Intent:* Users expect seamless access across multiple devices. ## Market Position {#market-position} Equate Heart Chart maintains a niche position as a hardware-tethered utility, with a 4.74 rating on iOS vs 3.31 on Android. The 1.4-star rating gap suggests that technical instability on Android is actively eroding the user base relative to the iOS experience. ## Monetization Strategy - **Model:** Free - **Tiers:** Free app with no IAP or subscription gates - **Analysis:** The app operates as a free value-add service to drive hardware sales for A&D Company, Limited. ## 🔴 User Sentiment (Medium Confidence: 63 of 99 reviews analyzed) {#user-sentiment} - **Overall Rating:** 4.62/5 - **Platform Split:** iOS 4.7/5 (12.4K ratings) | Android 3.3/5 (1.2K ratings) - **Overall Sentiment:** Frustrated - **Note:** The 4.62/5 store rating reflects cumulative history, while the Frustrated sentiment reflects recent user reviews analyzed by our AI pipeline. ### Top Praises - **Wireless blood pressure monitoring provides a convenient way to track heart health metrics over time** - **Simple interface design allows users to view daily averages and individual readings for medical appointments** ### Top Complaints (Impact Areas) - **Bluetooth connectivity failures prevent the app from syncing readings from the monitor to the phone** ## SWOT Analysis {#swot} **Core Strengths:** - Proprietary Bluetooth sync with Equate hardware creates a high switching cost for existing monitor owners. **Growth Levers:** - Adding manual entry editing would resolve the top-requested history management frustration. ## Recent Changes (v2 → v3) {#recent-changes} The report identifies a critical performance divergence between iOS and Android platforms, shifting the strategic focus toward platform-parity integrations like Google Health Connect. **Overall trend**: Mixed **Compared at**: 2026-08-11 ### High-impact changes - **[Shifted] Platform Performance Divergence** (positioning) ### Medium-impact changes - **[Added] Android-Specific Weakness** (swot) - **[Shifted] Outlook Trend Adjustment** (sentiment) ## What's New - **Latest (v3.0.5, 2 weeks ago):** Redesigned UI, added support for Equate UA-6010BLEWM/UA-8010BLEWM, integrated AHA-based blood pressure categories, and added customizable reminders. ## App Momentum (Maintenance) {#momentum} - Shipped UI redesign in latest release. - Expanded support for Equate monitor series. - Added AHA-based blood pressure categorization. > **Cadence:** 1 total versions · 1 majors in last 6 months · 20 days since last update ## The "So What?" (Strategic Takeaway) {#so-what} Equate Heart Chart is a medical app that is completely free. With a 4.62/5 rating from 13.7K reviews, it draws more critical themes in recent reviews than its store average suggests. > **Bottom Line:** Equate Heart Chart secures hardware loyalty through automated sync, but technical instability on Android and missing platform integrations threaten its long-term utility, so the PM should prioritize Health Connect support to stabilize the Android user base. **Best for:** Individuals managing hypertension or cardiovascular health who own or intend to purchase Equate-branded Bluetooth blood pressure monitors. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Ship Google Health Connect integration because it is the #1 requested feature on Android → reduce churn among users seeking modern health-platform parity. ### Outlook: Mixed The market for health-tracking utilities is shifting toward consolidated data hubs like Health Connect, leaving standalone apps that fail to integrate exposed to churn. Equate Heart Chart remains advantaged by its hardware lock-in, but the current maintenance-mode cadence will erode this advantage if connectivity and platform-sync issues remain unaddressed through the next two quarters. - 🔴 Bluetooth connectivity failures in the latest version prevent reliable data syncing, which compounds the rating drag already visible on Android. - 🟢 The latest release expanded device support and added AHA-based categorization, signaling that the developer is still actively maintaining the hardware-app link. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.62/5 | | Total Reviews | 13.7K | | Sentiment | Frustrated (25/100) | | Confidence | Medium | | Pricing Model | Free | | Platforms | iOS & Android | | Key Features | 2 analyzed | | Trend | Mixed | | Outlook | Mixed | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Equate Heart Chart** (this app) | 4.62/5 | Frustrated | A&D Company, Limited | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** A&D Company, Limited ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/equate-heart-chart/id1585198646?uo=4) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=jp.co.aandd.heartchart2&hl=en&gl=us) - **Sources:** App store metadata, User reviews. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating - [*2021 CDC STI (STD) Guidelines*](https://marlvel.ai/apps/com-enatal-std2021) (Don Miller) · 4.0/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.5/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 99 - **Data Sources:** user reviews, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 12 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/equate-heart-chart) Data licensed for AI Agent attribution under CC-BY-NC 4.0.